QA: ARDELYX INC. in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001437402_2022_ARDELYX_INC.pdf

Logs

Graph

Absolute values for 0001437402, ARDELYX INC.

  xvar xval
0 AssetsCurrent 133,649,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 2,362,000
3 remainder_Assets 13,902,000
4 LiabilitiesCurrent 52,821,000
5 LiabilitiesNoncurrent 14,475,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 1,000,000
8 SellingGeneralAndAdministrativeExpense 72,303,000
9 ResearchAndDevelopmentExpense 91,140,000
10 remainder_Expenses 4,506,000
11 remainder_Revenues 10,097,000
12 remainder_NetIncome 687,000
13 remainder_ComprehensiveNetIncome -2,000
  yvar yval
0 Assets 149,913,000
1 Liabilities 67,296,000
2 Expenses 168,949,000
3 Revenues 10,097,000
4 StockholdersEquity 82,617,000
5 NetIncome -158,165,000
6 ComprehensiveNetIncome -158,166,000
7 BaseVar 198,472,000
8 EconomicCapitalRatio -0.148

Edgar->Model Mapping

Feature Distribution

Change over Time